The effects of nasal decongestion on obstructive sleep apnoea severity in people with tetraplegia

Completed

• Conditions: Obstructive sleep apnoea; Tetraplegia; Respiratory - Sleep apnoea; Neurological - Other neurological disorders

• Registration Number: ACTRN12615000229572
• Lead Sponsor: Austin Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-03-12
• Study Completion: 2016-10-31
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

Tetraplegia
obstructive sleep apnoea as defined as having an apnoea hypopnoea index of greater than 10 events per hour

Exclusion Criteria

Neurologic condition other than tetraplegia
Uncontrolled hypertension
Significant head injury
Ongoing hypercapnic ventilatory failure
Allergy to phenylephrine or lignocaine
Inability to provide informed consent
Fixed nasal obstruction (i.e. nasal fracture or deviated septum)
Use of other medication that could influence nasal patency
Use of bronchodilators or corticosteroid inhalers

Study & Design

• Study Type: Interventional
• Study Design: Not specified